Alkem Laboratories Limited
Alkem Laboratories Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: ALKEM and BSE: 539523 (ISIN INE540L01014).
It has a market capitalisation of ₹59,823 crore, a last close of ₹5,004 on 2026-10-19, a one-year return of -10.3%.
Valuation: a price-to-earnings ratio of 27.73x, a price-to-book ratio of 4.33x, a dividend yield of 1.1%.
Profitability: return on equity of 17.8%, return on capital employed of 20.3%, an operating margin of 20.1%.
Growth: sales growth of 8.2% a year over three years, net profit growth of 32.7% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.12x, promoter holding of 49.7%.
| Metric | Value |
|---|---|
| Market capitalisation | 59,823 |
| Last close | ₹5,004 |
| P/E (TTM) | 27.73x |
| P/B | 4.33x |
| Dividend yield | 1.1% |
| ROE (FY) | 17.8% |
| ROCE (FY) | 20.3% |
| Operating margin (TTM) | 20.1% |
| Sales growth, 3-year CAGR | 8.2% |
| Profit growth, 3-year CAGR | 32.7% |
| Debt / equity | 0.12x |
| Promoter holding | 49.7% |
| 1-year return | -10.3% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means